NCT00834925Unknown4 期
Low Dose of Diltiazem for Rate Control of Atrial Fibrillation
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 入组人数
- 380
- 试验地点
- 1
- 主要终点
- Success rate of rate control
研究概览
简要总结
This study is to show the efficacy and safety of low dose diltiazem for the treatment of atrial fibrillation with rapid ventricular response in emergency room. We will compare the standard dose of diltiazem(0.25mg/kg) with low dose diltiazem(0.1mg/kg)in atrial fibrillation with rapid ventricular response in ED.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •atrial fibrillation with rapid ventricular response in emergency room
排除标准
- •systolic blood pressure<90mmHg
- •no consent
研究组 & 干预措施
low dose diltiazem
Experimental
干预措施: low dose diltiazem (Drug)
结局指标
主要结局
Success rate of rate control
时间窗: in 30 minutes
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Diltiazem in the Treatment of Atrial Fibrillation or Atrial Flutter With Rapid Ventricular RateAtrial Fibrillation With Rapid Ventricular ResponseHypotension Drug-InducedNCT05661942Wake Forest University Health Sciences92
已完成
4 期
Oral vs Intravenous Diltiazem for Rapid Atrial Fibrillation/Flutter TrialAtrial Fibrillation and FlutterNCT03472495Virginia Commonwealth University19
终止
1 期
Evaluate a Medication on How Hunger and Appetite Are Influenced by SmellFood IntakeNCT01021176Pennington Biomedical Research Center12
已完成
4 期
Reduction of Atrial Fibrillation Study in Patients Undergoing Coronary Artery Bypass Grafting. (RASCABG 1 Study)Coronary Artery Bypass GraftingAtrial FibrillationNCT00287209University of Aarhus250
已完成
3 期
RATe Control in Atrial FibrillationAtrial FibrillationNCT00313157Asker & Baerum Hospital80